News Author: Sharon Worcester Publish date: June 28, 2021
Cemiplimab immunotherapy is now approved in the European Union and the United States for certain BCCs, CSCCs, and NSCLCs.
News Author: Sharon Worcester Publish date: June 22, 2021
The American Society of Clinical Oncology (ASCO) now recommends offering 1 year of adjuvant Read More
News Author: Sharon Worcester Publish date: June 22, 2021
The tool shows promise for identifying those whose cancer is likely to recur despite undergoing postlumpectomy radiotherapy.
News Author: Sharon Worcester Publish date: June 4, 2021
Olaparib improved invasive and distant DFS when used following adjuvant or neoadjuvant chemotherapy in patients w...
News Author: Sharon Worcester Publish date: June 1, 2021
Adding bevacizumab to second-line osimertinib provided no benefit versus osimertinib alone for advanced non–small...
News Author: Sharon Worcester Publish date: May 27, 2021
Findings from a phase 3 trial failed to support those from a prior study showing that poloxamer 188 shortened painful vaso-occlusive episodes in si...
News Author: Sharon Worcester Publish date: May 21, 2021
There was an overall 1.3% annual increase in oropharyngeal, anal, rectal, and vulvar cancers in women, and a 2.3%...
News Author: Sharon Worcester Publish date: May 13, 2021
About 70% of patients experience hepatic or extrahepatic recurrence after conventional hepatectomy, according to ...
Article Author: Sharon Worcester Publish date: April 30, 2021
Oncologists now accept that hyperprogression on immunotherapy, in which a patient fares much worse than expected,...
News Author: Sharon Worcester Publish date: April 21, 2021
“The favorable safety and toxicity profile of Bv in combination with chemotherapy for high-risk pediatric patient...
News Author: Sharon Worcester Publish date: April 16, 2021
Nivolumab is now approved for the frontline treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and eso...
News Author: Sharon Worcester Publish date: April 15, 2021
The efficacy in these studies is notable considering the challenges of treating mantle cell lymphoma patients who...
News Author: Sharon Worcester Publish date: April 8, 2021
Palliative care improved several outcome measures and should be used early and often in patients with hematologic...
News Author: Sharon Worcester Publish date: April 1, 2021
Transplant in carefully selected patients “can be justified in older age groups and provide clinically meaningful...
News Author: Sharon Worcester Publish date: March 31, 2021
Adding oxaliplatin to fluoropyrimidine should be the standard of care adjuvant treatment in this setting. <...